S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

GILD Gilead Sciences Inc

65.51

0.31 (0.48%)

May 01 2024 - Closed

Delayed by 15 minutes

Sen. Wyden releases 'principles for drug pricing reform'

To read the full story on Seeking Alpha, click here.

Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Gilead Sciences Charts.

Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Gilead Sciences Charts.

Gilead Sciences Inc News

Gilead Sciences to Present at Upcoming Investor Conferences
Tuesday 30 April 2024 (1 day ago) • Business Wire

FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV
Friday 26 April 2024 (6 days ago) • Business Wire

Exxon Mobil Net Profit Drops 28% to $8.22 Billion, Atlassian Surprises with Revenue Boost and Co-CEO Exit, and More in Earnings
Friday 26 April 2024 (6 days ago) • IH Market News

Gilead Sciences Announces First Quarter 2024 Financial Results
Thursday 25 April 2024 (6 days ago) • Business Wire

U.S. Futures Drop in Pre-Market Trading as Tech Stocks Plunge After Meta Issues Gloomy Forecast
Thursday 25 April 2024 (7 days ago) • IH Market News

Gilead Sciences to Release First Quarter 2024 Financial Results on Thursday, April 25, 2024
Monday 8 April 2024 (3 weeks ago) • Business Wire

FDA Expands Indication for Gilead's Vemlidy (Tenofovir Alafenamide) to Treat Chronic HBV Infection in Pediatric Patients as Young as Six
Thursday 28 March 2024 (1 month ago) • Business Wire

Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program
Thursday 28 March 2024 (1 month ago) • GlobeNewswire Inc.

Gilead Sciences Announces Completion of Acquisition of CymaBay
Friday 22 March 2024 (1 month ago) • Business Wire

Center for Disease Analysis Foundation Announces First Round of Grantees for the CDAF-Relink Grant
Monday 18 March 2024 (1 month ago) • Business Wire

Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
Monday 11 March 2024 (2 months ago) • Edgar (US Regulatory)

Gilead Sciences Announces Expiration of Hart-Scott-Rodino Waiting Period for CymaBay Tender Offer
Monday 11 March 2024 (2 months ago) • Business Wire

More Gilead Sciences Inc News Articles

Global Developments (PK)

FBEC Worldwide (PK)

NaturalShrimp (QB)

Mullen Automotive

Atacama Resources (PK)

NioCorp Developments

Fannie Mae (QB)

Branded Legacy (PK)

MicroCloud Hologram

Tonner One World (PK)

International Star (PK)

Virexit Technologies (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions